Article
Early insulin therapy prevents beta cell loss in a mouse model for permanent neonatal diabetes (Munich Ins2(C95S)).
Diabetologia - 1 Feb 2012
Kautz S, van Bürck L, Schuster M, Wolf E, Wanke R, Herbach N
Abstract excerpt
AIMS: Heterozygous male Munich Ins2(C95S) mutant mice, a model for permanent neonatal diabetes mellitus, demonstrate a progressive diabetic phenotype with severe loss of functional beta cell mass. The aim of this study was to investigate the influence of early insulin treatment on glucose homeostasis and beta cell destruction in male Munich Ins2(C95S) mutants. METHODS: One group of male Ins2(C95S) mutants was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
